Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. Lopez-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, et al. J Infect Dis 2020 Dec 15. pii: 6034203. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Lopez-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, et al. Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. J Infect Dis 2020 Dec 15. pii: 6034203. doi: 10.1093.
PMID: 33319249